Skip to search.
 TSX Up 0.44% TSX Ventures Up 0.66%

Pluristem Therapeutics, Inc. (PSTI)

-NasdaqCM
2.51 Down 0.01(0.40%) Jul 1, 3:59PM EDT
Add to Portfolio
Prev Close:2.52
Open:2.53
Bid:2.48 x 200
Ask:2.52 x 300
1y Target Est:5.50
Beta:-1.34
Next Earnings Date:N/A
Day's Range:2.50 - 2.54
52wk Range:2.32 - 3.78
Volume:196,765
Avg Vol (3m):160,416
Market Cap:197.04M
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
PSTIDown 0.40%197.04M
ASTM 0.00%N/A
ACTC 0.00%N/A
OSIRUp 0.51%672.67M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):473.71
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.38
Quarterly EPS Est (Jun-15) :-0.10
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The company focuses on the research, development, clinical trial, and manufacture of cell therapeutics products and related tech... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback